Clinical Trial Update: Combined STN/SNr-DBS for the Treatment of Refractory Gait Disorders in Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combined subthalamic nucleus and substantia nigra pars reticulata deep brain stimulation for refractory gait disorders in Parkinson's d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED